日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody

中和泛 ELR+CXC 趋化因子单克隆抗体的发现和表征

Jeffrey S Boyles, Catherine B Beidler, Beth A Strifler, Daniel S Girard, Zhanna Druzina, Jim D Durbin, Michelle L Swearingen, Linda N Lee, Kristine Kikly, Sudhakar Chintharlapalli, Derrick R Witcher

Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319

基于成纤维细胞生长因子 21 的临床候选药物 LY2405319 的合理设计

Alexei Kharitonenkov, John M Beals, Radmila Micanovic, Beth A Strifler, Radhakrishnan Rathnachalam, Victor J Wroblewski, Shun Li, Anja Koester, Amy M Ford, Tamer Coskun, James D Dunbar, Christine C Cheng, Christopher C Frye, Thomas F Bumol, David E Moller